Interactive changes between macrophages and adipocytes

Clinical and Vaccine Immunology

Volumn 17, Issue 4, 2010, Pages 651-659

  Xie, Linglin ^a   Ortega, M Teresa ^a   Mora, Silvia ^b   Chapes, Stephen K ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN KINASE B; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROADIPOCYTE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950682106     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00494-09     Document Type: Article

References (47)

1. Ailhaud, G. 2006. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C. R. Biol. 329:570-577.
2. Ajuwon, K. M., and M. E. Spurlock. 2005. Adiponectin inhibits LPS-induced NF-KB activation and IL-6 production and increases PPAR72 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R1220-R1225.
3. Beharka, A. A., J. W. Armstrong, and S. K. Chapes. 1998. Macrophage cell lines derived from major histocompatibility complex II-negative mice. In Vitro Cell. Dev. Biol. Anim. 34:499-507.
4. Bluher, M., M. Fasshauer, A. Tonjes, J. Kratzsch, M. R Schon, and R. Paschke. 2005. Association of interleukin-6, C-reactive protein, interleu-kin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp. Clin. Endocrinol. Diabetes 113:534-537.
5. Carey, A. L., G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M. J. Watt, D. E. James, B. E. Kemp, B. K. Pedersen, and M. A. Febbraio. 2006. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55:2688-2697.
6. Chacon, M. R, J. M. Fernandez-Real, C. Richart, A. Megia, J. M. Gomez, M. Miranda, E. Caubet, R Pastor, C. Masdevall, N. Vilarrasa, W. Ricard, and J. Vendrell. 2007. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study. Obesity (Silver Spring) 15:664-672.
7. Chapes, S. K., and A. A. Beharka. 1995. Lipopolysaccharide is required for the lethal effects of enterotoxin B after D-GALACTOSAMINE SENSITIZATION. J. ENDOTOXIN RES. 2:263-271.
8. Constant, V. A., A. Gagnon, A. Landry, and A. Sorisky. 2006. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49:1402-1411.
9. De Taeye, B., T. Novitskaya, O. P. McGuinness, L. Gleaves, M. Medda, J. W. Covington, and D. E. Vaughan. 2007. Macrophage TNF-a contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293:E713-E725.
10. Dinarello, C. A. 1997. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321S-329S.
11. Dugani, C. B., and A. Klip. 2005. Glucose transporter 4: cycling, compartments and controversies. EMBO Rep. 6:1137-1142.
12. Eierman, D. F., C. E. Johnson, and J. S. Haskill. 1989. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142:1970-1976.
13. Farmer, S. R 2006. Transcriptional control of adipocyte formation. Cell Metab. 4:263-273.
14. Fernandez-Veledo, S., R. Hernandez, T. Teruel, J. A. Mas, M. Ros, and M. Lorenzo. 2006. Ceramide mediates TNF-a-induced insulin resistance on GLUT4 gene expression in brown adipocytes. Arch. Physiol. Biochem. 112: 13-22.
15. Guilbert, J. J. 2003. The world health report 2002\reducing risks, promoting healthy life. Educ. Health (Abingdon, Engl.) 16:230.
16. Guzik, T. J., D. Mangalat, and R Korbut. 2006. Adipocytokines\novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57:505-528.
17. Hauner, H. 2004. The new concept of adipose tissue function. Physiol. Behav. 83:653-658.
18. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444:860-867.
19. Jager, J., T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J. F. Tanti. 2007. Interleukin-1|3-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251.
20. Lacasa, D., S. Taleb, M. Keophiphath, A. Miranville, and K. Clement. 2007. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148:868-877.
21. Lagathu, C, J. P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron. 2003. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun. 311:372-379.
22. Lagathu, C, L. Yvan-Charvet, J. P. Bastard, M. Maachi, A. Quignard-Boulange, J. Capeau, and M. Caron. 2006. Long-term treatment with interleukin-1p induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173.
23. Long, S. D., and P. H. Pekala. 1996. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem. J. 319(Pt 1):179-184.
24. Lumeng, C. N., S. M. Deyoung, and A. R Saltiel. 2007. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292:E166-E174.
25. Medina, E. A., R. R. Afsari, T. Ravid, S. S. Castillo, K. L. Erickson, and T. Goldkorn. 2005. Tumor necrosis factor-a decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146:2726-2735.
26. Neels, J. G., and J. M. Olefsky. 2006. Inflamed fat: what starts the fire? J. Clin. Invest. 116:33-35.
27. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
28. Potts, B. E., and S. K. Chapes. 2008. Functions of C2D macrophage cells after adoptive transfer. J. Leukoc. Biol. 83:602-609.
29. Potts, B. E., M. L. Hart, L. L. Snyder, D. Boyle, D. A. Mosier, and S. K. Chapes. 2008. Differentiation of C2D macrophage cells after adoptive transfer. Clin. Vaccine Immunol. 15:243-252.
30. Rotter, V., I. Nagaev, and U. Smith. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-a, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278:45777-45784.
31. Ruan, H., N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish. 2002. Tumor necrosis factor-a suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-KB activation by TNF-a is obligatory. Diabetes 51:1319-1336.
32. Schenk, S., M. Saberi, and J. M. Olefsky. 2008. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118:2992-3002.
33. Spranger, J., A. Kroke, M. Mohlig, K. Hoffmann, M. M. Bergmann, M. Ristow, H. Boeing, and A. F. Pfeiffer. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Pots-dam Study. Diabetes 52:812-817.
34. Stephens, J. M., and P. H. Pekala. 1991. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-a. J. Biol. Chem. 266:21839-21845.
35. Stouthard, J. M., R. P. Oude Elferink, and H. P. Sauerwein. 1996. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 220:241-245.
36. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor a. Arterioscler. Thromb. Vasc. Biol. 25:2062-2068.
37. Suzawa, M., I. Takada, J. Yanagisawa, F. Ohtake, S. Ogawa, T. Yamauchi, T. Kadowaki, Y. Takeuchi, H. Shibuya, Y. Gotoh, K. Matsumoto, and S. Kato. 2003. Cytokines suppress adipogenesis and PPAR-7 function through the TAK1/TAB1/NIK cascade. Nat. Cell Biol. 5:224-230.
38. Trayhurn, P., and I. S. Wood. 2005. Signalling role of adipose tissue: adipo-kines and inflammation in obesity. Biochem. Soc. Trans. 33:1078-1081.
39. Uysal, K. T., S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-a function. Nature 389:610-614.
40. Ventre, J., T. Doebber, M. Wu, K. MacNaul, K. Stevens, M. Pasparakis, G. Kollias, and D. E. Moller. 1997. Targeted disruption of the tumor necrosis factor-a gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531.
41. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808.
42. Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119.
43. Xie, L., D. Boyle, D. Sanford, P. E. Scherer, J. E. Pessin, and S. Mora. 2006. Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles. J. Biol. Chem. 281:7253-7259.
44. Xie, L., C. P. O'Reilly, S. K. Chapes, and S. Mora. 2008. Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes. Bio-chim. Biophys. Acta 1782:99-108.
45. Xing, H., J. P. Northrop, J. R. Grove, K. E. Kilpatrick, J. L. Su, and G. M. Ringold. 1997. TNF a-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR7 without effects on Pref-1 expression. Endocrinology 138:2776-2783.
46. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830.
47. Zoccali, C, F. Mallamaci, and G. Tripepi. 2003. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int. Suppl. 84:S65-S68.